Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Is There a Recipe for Successful Implementation of Registries for Rare Diseases?
Track : Track 17: Rare/Orphan Diseases
Program Code: 260
Date: Tuesday, June 25, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 153C
CHAIR :
 Martine Zimmermann, PharmD (SPKNON), Vice President, Global Regulatory Affairs, Alexion Pharma International Sŕrl, Switzerland
SPEAKER (S):
 Samantha Parker, MBA (SPKNON), Director of External Affairs and Rare Disease Partnerships, Orphan Europe, France
 Marshall Summar, MD (SPKSUP), Chief, Genetics and Metabolism, Children's National Medical Center, United States
 Larissa Lapteva, (SPKAGY), Medical Officer, Rare Diseases Program, Office of New Drugs, CDER, FDA, United States
Description
This session will describe how registries can support development of new drug for rare diseases, how they can contribute to regulatory approval, and decisions on access to orphan medicinal products.

Session Recording
(Code: 260)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Handout Online
(Code: 260)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON3 Comp Access: Tuesday Online Access Package - June 25, 2013
Is There a Recipe for Successful Implementation of Registries for Rare Diseases?